Tracking Cognitive Decline and Understanding Study Dropout in PD-GBA
Objective: Analyze which cognitive functions are affected in PD_GBA+, and which factors are linked to dropout risk. Background: People with Parkinson's disease (PD) who carry…The Cultural Validation of the Montreal Cognitive Assessment in Bangladeshi Adults with Parkinson’s Disease in East London
Objective: This study investigated the cultural validity of the Montreal Cognitive Assessment (MoCA) in Bangladeshi adults with Parkinson’s disease in East London using the validated…Theta and Beta Oscillations Track Happiness and Surprise in the Subthalamic Nucleus After Reward Outcome
Objective: To identify subcortical neural biomarkers of happiness and reward evaluation through sensing-enabled deep brain stimulation (DBS) in people with Parkinson’s Disease (PwPD). Background: Integrating…Approach into the genetics of cognitive performance in Mexican Parkinson’s Disease patients.
Objective: To compare the allele frequencies of genetic variants associated with cognitive impairment between Parkinson's Disease (PD) patients and controls and to examine their interaction…Neurocognitive Functioning and Neurobehavioral Alterations in a Group of Patients Diagnosed with Idiopathic Parkinson’s Disease Without Dementia by Deep Brain Stimulation. Descriptive Study of the ESDEPARK Scale.
Objective: To identify the clinical correlation between neurocognitive functioning and depressive symptomatology in patients with IPDWD, assessed by a new scale (ESDEPARK) that measures depression…Utilizing the Levodopa Challenge Test to Clarify Clinical Complaints Following Levodopa Administration: A Case Series
Objective: To characterize subjective clinical complaints reported by patients with Parkinson's Disease (PD) following levodopa administration and evaluate the utility of the levodopa challenge test…Early Indicators of Alpha-synuclein Aggregation: Can Autonomic and Cognitive Markers Predict Prodromal Parkinson’s Disease?
Objective: To develop a model that predicts alpha synuclein (a-syn) status of patients at risk of Parkinson’s disease (PD) using non-motor and cognitive tests that…Safety and tolerability of overnight switching from Eetacapone to Opicapone in fluctuating Parkinson’s disease: An open-label preliminary trial in Koreans
Objective: Objectives: 1. Efficacy - Opicapone 50mg qd. to determine effectiveness of optimal dose for switching. 2. Tolerability and safety - compare symptoms and adverse…A Comparative Analysis of Water-Based versus Land-Based Exercise Interventions for Improving Quality of Life in Parkinson’s Disease: A Systematic Review
Objective: To compare the effectiveness of water-based and land-based exercise interventions in improving quality of life (QoL) and motor function in individuals with Parkinson’s disease…Supporting Movement Disorders Specialists with Digital Tools that Integrate with their Workflows
Objective: Our work investigates how to design digital tools to assist movement disorders specialists in their clinical work. Background: Digital tools are ubiquitous in healthcare;…
- « Previous Page
- 1
- …
- 83
- 84
- 85
- 86
- 87
- …
- 436
- Next Page »